
Journal of Shanghai Jiao Tong University (Medical Science)
MA Fangfang(
), QIN Jiejie, REN Lingjie, TANG Xiaomei, LIU Jia, SHI Minmin, JIANG Lingxi(
)
Received:2022-05-18
Accepted:2022-08-21
Online:2022-12-19
Published:2022-12-19
Contact:
JIANG Lingxi
E-mail:mafang704@163.com;jlx12120@rjh.com.cn
Supported by:CLC Number:
MA Fangfang, QIN Jiejie, REN Lingjie, TANG Xiaomei, LIU Jia, SHI Minmin, JIANG Lingxi. Establishment of a 3D culture model in vitro of pancreatic cancer primary cells using hydrogel microspheres[J]. Journal of Shanghai Jiao Tong University (Medical Science).
| 1 | ANSARI D, TINGSTEDT B, ANDERSSON B, et al. Pancreatic cancer: yesterday, today and tomorrow[J]. Future Oncol, 2016, 12(16): 1929-1946. |
| 2 | KUNZMANN V, SIVEKE J T, ALGÜL H, et al. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial[J]. Lancet Gastroenterol Hepatol, 2021, 6(2): 128-138. |
| 3 | BACHET J B, HAMMEL P, DESRAMÉ J, et al. Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial[J]. Lancet Gastroenterol Hepatol, 2017, 2(5): 337-346. |
| 4 | SEINO T, KAWASAKI S, SHIMOKAWA M, et al. Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression[J]. Cell Stem Cell, 2018, 22(3): 454-467.e6. |
| 5 | TIRIAC H, BELLEAU P, ENGLE D D, et al. Organoid profiling identifies common responders to chemotherapy in pancreatic cancer[J]. Cancer Discov, 2018, 8(9): 1112-1129. |
| 6 | D'ANDREA A D. Mechanisms of PARP inhibitor sensitivity and resistance[J]. DNA Repair (Amst), 2018, 71: 172-176. |
| 7 | COLEMAN O, HENRY M, O'NEILL F, et al. Proteomic analysis of cell lines and primary tumors in pancreatic cancer identifies proteins expressed only in vitro and only in vivo[J]. Pancreas, 2020, 49(8): 1109-1116. |
| 8 | BYRNE A T, ALFÉREZ D G, AMANT F, et al. Interrogating open issues in cancer precision medicine with patient-derived xenografts[J]. Nat Rev Cancer, 2017, 17(4): 254-268. |
| 9 | BARNES R P, DE ROSA M, THOSAR S A, et al. Telomeric 8-oxo-guanine drives rapid premature senescence in the absence of telomere shortening[J]. Nat Struct Mol Biol, 2022, 29(7): 639-652. |
| 10 | SUGA H. Making pituitary hormone-producing cells in a dish[Review][J]. Endocr J, 2016, 63(8): 669-680. |
| 11 | SCALISE M, MARINO F, SALERNO L, et al. From spheroids to organoids: the next generation of model systems of human cardiac regeneration in a dish[J]. Int J Mol Sci, 2021, 22(24): 13180. |
| 12 | WHITAKER R, HERNAEZ-ESTRADA B, HERNANDEZ R M, et al. Immunomodulatory biomaterials for tissue repair[J]. Chem Rev, 2021, 121(18): 11305-11335. |
| 13 | KIM Y H, DAWSON J I, OREFFO R O C, et al. Gelatin methacryloyl hydrogels for musculoskeletal tissue regeneration[J]. Bioengineering (Basel), 2022, 9(7): 332. |
| 14 | HUCH M, GEHART H, VAN BOXTEL R, et al. Long-term culture of genome-stable bipotent stem cells from adult human liver[J]. Cell, 2015, 160(1/2): 299-312. |
| 15 | HERSEL U, DAHMEN C, KESSLER H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond[J]. Biomaterials, 2003, 24(24): 4385-4415. |
| 16 | ZADPOOR A A. Meta-biomaterials[J]. Biomater Sci, 2019, 8(1): 18-38. |
| 17 | 何家辰, 刘畅, 陈迟迟, 等. 制备负载细胞可注射微球及体外评价[J]. 中国组织工程研究, 2022, 26(28): 4483-4488. |
| HE J C, LIU C, CHEN C C, et al. Preparation and in vitro evaluation of injectable microspheres loaded with cells[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(28): 4483-4488. | |
| 18 | WU J, LI G, YE T, et al. Stem cell-laden injectable hydrogel microspheres for cancellous bone regeneration[J]. Chem Eng J, 2020, 393: 124715. |
| 19 | FEIG C, JONES J O, KRAMAN M, et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer[J]. Proc Natl Acad Sci U S A, 2013, 110(50): 20212-20217. |
| 20 | ZHAO X, LIU S, YILDIRIMER L, et al. Injectable stem cell-laden photocrosslinkable microspheres fabricated using microfluidics for rapid generation of osteogenic tissue constructs[J]. Adv Funct Mater, 2016, 26(17): 2809-2819. |
| 21 | KORNEEV K V, ATRETKHANY K N, DRUTSKAYA M S, et al. TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis[J]. Cytokine, 2017, 89: 127-135. |
| 22 | SINGH R, MISHRA M K, AGGARWAL H. Inflammation, immunity, and cancer[J]. Mediators Inflamm, 2017, 2017: 6027305. |
| 23 | BAGHBAN R, ROSHANGAR L, JAHANBAN-ESFAHLAN R, et al. Tumor microenvironment complexity and therapeutic implications at a glance[J]. Cell Commun Signal, 2020, 18(1): 59. |
| 24 | KIM J, BAE J S. Tumor-associated macrophages and neutrophils in tumor microenvironment[J]. Mediators Inflamm, 2016, 2016: 6058147. |
| 25 | PETITPREZ F, MEYLAN M, DE REYNIÈS A, et al. The tumor microenvironment in the response to immune checkpoint blockade therapies[J]. Front Immunol, 2020, 11: 784. |
| 26 | HANAHAN D, COUSSENS L M. Accessories to the crime: functions of cells recruited to the tumor microenvironment[J]. Cancer Cell, 2012, 21(3): 309-322. |
| 27 | ABADJIAN M Z, EDWARDS W B, ANDERSON C J. Imaging the tumor microenvironment[J]. Adv Exp Med Biol, 2017, 1036: 229-257. |
| 28 | ÖHLUND D, HANDLY-SANTANA A, BIFFI G, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer[J]. J Exp Med, 2017, 214(3): 579-596. |
| 29 | VON AHRENS D, BHAGAT T D, NAGRATH D, et al. The role of stromal cancer-associated fibroblasts in pancreatic cancer[J]. J Hematol Oncol, 2017, 10(1): 76. |
| [1] | XU Tongtong, RUAN Huitong. Effects of hydrogel microspheres loaded with interleukin-4 on neural functional recovery by modulating the immune microenvironment after stroke [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(9): 1161-1170. |
| [2] | TANG Kairan, FENG Chengling, HAN Bangmin. Integrated single-cell and transcriptome sequencing to construct a prognostic model of M2 macrophage-related genes in prostate cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(5): 549-561. |
| [3] | SUN Chenwei, HAI Wangxi, QU Qian, XI Yun. [18F]F-FMISO and [18F]F-FLT PET/CT dual-nuclide imaging for in vivo prediction of drug resistance in pancreatic cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(1): 60-68. |
| [4] | ZHANG Yesheng, YANG Yijing, HUANG Yiwen, SHI Longyu, WANG Manyuan, CHEN Sisi. Research progress in immune cells regulating drug resistance of tumor cells in tumor microenvironment [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(7): 830-838. |
| [5] | LIU Linnan, FENG Li, WANG Long, LIU Jiayin, FAN Zhisong. Research progress in the expression of versican in malignant tumors and its biological roles [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(4): 525-530. |
| [6] | YU Siwei, XU Ziqi, TAO Mengyu, FAN Guangjian. Mechanistic study on the promotion of pancreatic cancer progression through upregulation of ZNF143 by dysregulated fatty acid metabolism [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(10): 1255-1265. |
| [7] | LI Yu, JIANG Yifan, TONG Rongliang, CHEN Diyu, WU Jian. Research progress in the relationship between FOXM1 and neoplasm metabolism [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(10): 1323-1329. |
| [8] | WEI Lanyi, XUE Xiaochuan, CHEN Junjun, YANG Quanjun, WANG Mengyue, HAN Yonglong. Research progress of tumor-associated macrophages in immune microenvironment and targeted therapy of osteosarcoma [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(5): 624-630. |
| [9] | WU Ruifang, FENG Ming, MENG Jian. Review of role of fatty acid binding protein-4 in obesity-associated tumors [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(10): 1311-1316. |
| [10] | QIN Yahan, ZHANG Ke, ZHANG Mengyu, SHEN Jie, PENG Meiyu. Research progress of MDSCs-targeted immunotherapy for pancreatic cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(10): 1317-1323. |
| [11] | MA Fangfang, QIN Jiejie, REN Lingjie, TANG Xiaomei, LIU Jia, SHI Minmin, JIANG Lingxi. Establishment of a 3D culture model in vitro of pancreatic cancer primary cells using hydrogel microspheres [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(1): 79-87. |
| [12] | LIN Jiayu, QIN Jiejie, JIANG Lingxi. Progress in metabolism of the immune cells in tumor microenvironment [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(8): 1122-1130. |
| [13] | WANG Yuxin, SUN Ruiqi, LIU Jianhua, HE Weina. Development of pH-responsive fluorescent probe for tumor microenvironment imaging [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(7): 875-884. |
| [14] | XU Jingxuan, DU Shaoqian, CAO Yuan, WANG Hongxia, HUANG Weiyi. MMP14 expression in pancreatic cancer and its correlation with characteristics of tumor immune microenvironment [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(3): 312-322. |
| [15] | Jing-wei LI, Li-wen WANG, Ling-xi JIANG, Qian ZHAN, Hao CHEN, Bai-yong SHEN. Review of immunosuppressive tumor microenvironment of pancreatic cancer [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(8): 1103-1108. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||